New Report: U.S. CBD Sales to Reach $2.1B by 2020 With $450M From Hemp Industry

medicalmarijuana October 25, 2016 Comments Off on New Report: U.S. CBD Sales to Reach $2.1B by 2020 With $450M From Hemp Industry
New Report: U.S. CBD Sales to Reach $2.1B by 2020 With $450M From Hemp Industry

The Hemp Business Journal (HBJ), the hemp industry’s authority on big data and market intelligence, has released The CBD Report showing cannabidiol as one of the fastest growing market categories in the U.S. hemp and legal marijuana industries with a compound annual growth rate of 59%.

Partnering with market leading consumer data experts SPINS and BDS Analytics, market modeling experts and hemp insiders with years of experience and sales data, Hemp Business Journal estimates the total U.S. CBD market will grow to a $2.1 Billion market in consumer sales by 2020 with $450 million of those sales coming from hemp based sources. Projections to date for 2016 indicate the hemp-derived CBD market is poised to grow to $115 million by the end of the year.

The hemp-derived CBD market grew from a market that was barely noticeable a few years ago to $90 million in 2015 for consumer sales of CBD products. Hemp Business Journal shows another $112 million of marijuana-derived CBD products were sold through dispensaries in 2015, for a total CBD market size of $202 million in 2015 across all hemp and legal marijuana markets.

The CBD Report is the first comprehensive market overview to define and analyze the acceleration of the emerging CBD market category. The report features the first ever analysis across consumer sales in seven consumer channels including Dispensaries, Natural and Specialty Retail, Mass Market, Practitioner, Internet, Smoke/Head Shops and Pharmaceuticals. Until now, no other market report has combined analysis of hemp and legal marijuana consumer sales to show a cumulative view of where the broader cannabis industry is trending.

The CBD Report also includes an investment guide and coverage of market leading companies including GW Pharmaceuticals ( NASDAQ : GWPH ), Insys Therapeutics, CV Sciences ( OTCQB : CVSI ), Bluebird Botanicals, Atalo Holdings, CW Hemp, O.pen Vape, Dixie Elixirs and more.

“The CBD Report is the culmination of more than a year of focused market research. We’ve been to Israel, Europe, Canada and to farms, labs and retailers across the U.S. to cover the hemp industry. By analyzing consumer sales in the hemp and marijuana industries, we’ve provided the first view to investors, executives and regulators on what’s really happening with CBD, the hottest category in the broader multi-billion dollar cannabis industry,” said Hemp Business Journal Founder and Publisher, Sean Murphy.

With nearly a dozen states set to vote on cannabis laws in the coming November elections, 2017 marks a tipping point in which a majority of U.S. states will transition from cannabis prohibition to some form of regulated legal market. “If you want to capitalize on these upcoming market opportunities then this is the time to be informed with the most accurate and actionable market intelligence,” said Murphy.

Become an industry insider. Learn more about The CBD Report.

Comments are closed.